FTRE - יחס שווי חברה לקצב צמיחת הרווח Fortrea Clinical

סמל מסחרי של Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. is increasing profits through data automation and a global network of laboratories. On GURU.Markets, the weighted PEG ratio demonstrates the impact of a high dependency on external IT vendors and the current pivot toward debt reduction. The value of 0.44 reflects the latest metric value, helping to determine the extent to which the company's market value aligns with its growth rates.

FTRE יחס מחיר לרווח לקצב צמיחה Fortrea Corp (21.02.2024 - 16.11.2026)

פילוחי מדדים ואנליטיקה של חברת Fortrea Holdings Inc (FTRE)

- מחיר מניה וקונצנזוס הערכת שווי:
ניתוח כללי של החברה:Fortrea Clinical - FTRE
פריט של המותג Fortrea

The resilience of Fortrea Holdings Inc. (FTRE) depends on the volume of biotech R&D funding and the efficiency of clinical trial management. This indicator correlates the P/E multiple with earnings growth rates, allowing for the identification of an undervalued asset when values fall below one. By analyzing the weighted price-to-earnings-to-growth ratio, an investor identifies the business's margin of safety, filtering out risks associated with operational load and the volatility of client budgets.